Dare Bioscience, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -99.8% | -99.8% | -69.3% |
| FY2022 | -278.5% | -278.5% | -70.6% |
| FY2023 | 597.5% | 597.5% | -141.7% |
| FY2024 | 67.4% | 67.4% | -18.3% |
| FY2025 | -471.4% | -471.4% | -41.3% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -99.8% | -99.8% | -69.3% |
| FY2022 | -278.5% | -278.5% | -70.6% |
| FY2023 | 597.5% | 597.5% | -141.7% |
| FY2024 | 67.4% | 67.4% | -18.3% |
| FY2025 | -471.4% | -471.4% | -41.3% |